Wang, X., Huang, D., Xie, Y., Xie, Y., Shi, J., Hou, D., Du, F., Cao, Y., Gao, Q., Wang, Y., Wang, J., Gao, Z., Jin, X., Li, M., Hao, L., Wang, D., Zhang, B., Ren, G., Li, M., Gu, J. (2025). Neoadjuvant therapy with mFOLFOXIRI combined with camrelizumab and bevacizumab for microsatellite stable, locally advanced rectal cancer: A single-arm, open-label phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e15633